￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The maximum number of years that gratinumab cannot be used for more than

2026-02-01 22:25:32

Check Details
What is the progress related to roselixizumab?

2026-02-01 22:25:32

Check Details
How effective is niraparibabiraterone tablets in treating prostate cancer?

2026-02-01 22:25:32

Check Details
Who is suitable for the treatment of Enantuzumab?

2026-02-01 22:25:32

Check Details
Is tocilizumab a hormonal drug? What is the difference?

2026-02-01 22:25:32

Check Details
What are the precautions for using gaffetomab?

2026-02-01 22:25:32

Check Details
The time when roselixizumab was approved for marketing in China

2026-02-01 22:25:32

Check Details
What precautions should be taken when using Nirapali and Abiraterone Tablets?

2026-02-01 22:25:32

Check Details
Specific usage and dosage guidance of ernatumumab

2026-02-01 22:25:32

Check Details
Analysis of common side effects during tocilizumab treatment

2026-02-01 22:25:32

Check Details
Innovative treatments in 2025: Latest clinical applications and global market trends of Axitinib

2026-02-01 22:25:32

Check Details
What are the common side effects of olezarsen?

2026-02-01 22:25:32

Check Details
Category
相关知识